Cantel Medical (CMD) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Cantel Medical Corp   (NYSE: CMD)
 

Cantel Medical Growth Comparisons

Select each growth Category to receive further Information





CMD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 32.51 % 15.92 % 15.08 % 14.89 %
Q / Q Revenue Growth (Q1 MRQ) 6.77 % -1.66 % -2.3 % 2.02 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 11.37 % 1.13 % 6.93 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 7.26 % 3.83 % 3.56 % 3.64 %
Revenue 5 Year Average Growth 12.45 % 7.58 % 10.85 % 9.03 %


CMD's Growth Comparisons in III. Quarter 2021




With 32.51% year on year Revenue increase in the third quarter 2021, Cantel Medical outperformed the 15.92% rise in the Medical Equipment & Supplies industry, and 15.08% improvement in the Healthcare sector. Above the average sales gains in the Healthcare and in the Medical Equipment & Supplies industry, helped to elevate overall market growth to 14.89%.

Comparing the company's Revenue to the second quarter results, sales were higher by 6.77% . On the yearly basis, average annual sales growth for Cantel Medical is 12.45%, while S & P 500's including only Businesses with the third quarter 2021 earnings, average annual sales growth is 9.03% over the past five years.


Growth Rates of CMD's Income in the third quarter 2021


CMD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) 102.83 % 111.17 % 32.5 % 92.71 %
Sequential Operating Income Change (Q1 MRQ) 43.93 % -3.74 % 83.38 % 58.11 %
Y / Y Operating Income Growth (Q1 TTM) 121.51 % 0.36 % -12.74 % -6.23 %
Sequential Operating Income Growth (Q1 TTM) 21.32 % 20.05 % 9.28 % 19.42 %
Operating Income 5 Year Avg. Change -9.77 % 1 % 2.2 % 8.2 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 33.77 % 29.14 % 44.46 % 153.38 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) 74.99 % -36.14 % 144.66 % 61.73 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) 85.19 % -17.6 % -13.56 % 0.07 %
Sequential Income from Cont. Ops. Change (Q1 TTM) 11.41 % 6.94 % 15.74 % 28.52 %
Income from Cont. Ops. 5 Year Avg. Change -22.15 % 4.67 % 10.33 % 76.07 %

CMD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 33.77 % 29.29 % 39.36 % 144.01 %
Q / Q Net Income Growth (Q1 MRQ) 74.99 % -35.02 % 654.36 % 64.84 %
Y / Y Net Income Change (Q1 TTM) 85.19 % -16.16 % -19.18 % -0.39 %
Sequential Net Income Change (Q1 TTM) 11.41 % 7.64 % 17.16 % 27.86 %
Net Income 5 Year Avg. Growth -22.15 % 3.93 % 1.77 % 4.21 %

CMD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 35.14 % 13.67 % 44.46 % 153.38 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) 72.41 % -38.23 % 144.66 % 61.73 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) 85.07 % - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) 11.71 % - - 34.47 %
EPS from Cont. Ops. 5 Year Avg. Growth -22.71 % -5.03 % 10.33 % 76.07 %



CMD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 27.03 % 13.81 % 39.36 % 76.07 %
Q / Q EPS Net Growth (Q1 MRQ) 74.07 % -37.15 % 654.36 % 64.84 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - -27.73 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) 9.26 % - - 32.32 %
EPS Net 5 Year Avg. Change -22.57 % 3.93 % 1.77 % 4.21 %



With 27.03% year on year EPS increase in the third quarter, Cantel Medical outperformed the 13.81% rise in the Medical Equipment & Supplies industry, but Cantel Medical 's growth compares unfavorably, to the 39.36% EPS increase in the Healthcare sector.

The bottom-line grew by 74.07% from the second quarter. Average yearly income per share growth for Cantel Medical is -22.57%, while S & P 500's average annual income per share increase is 4.21% over the five years, including only Businesses with the third quarter 2021 earnings reports.

CMD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) -42.4 % 127.27 % 101.87 % 156.25 %
Sequential Free Cash Flow Change (Q1 MRQ) -29.74 % -47.26 % -24.35 % -39.04 %
Y / Y Free Cash Flow Change (Q1 TTM) 137.8 % 17.62 % 40.36 % -12.8 %
Sequential Free Cash Flow Change (Q1 TTM) -10.81 % 6.62 % 10.43 % 8.85 %
Free Cash Flow 5 Year Avg. Change 17.34 % 12.46 % 14.45 % 20.95 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - -84.63 % -75.89 %
Sequential Net Cash Flow Change (Q1 MRQ) - - - -1.91 %
Y / Y Net Cash Flow Change (Q1 TTM) 374.24 % -61.45 % - 12.22 %
Sequential Net Cash Flow Change (Q1 TTM) - -71.18 % - -43.24 %
Net Cash Flow 5 Year Avg. Change - 29.86 % 45.88 % 111.43 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 92.47 % -1.61 % 6.55 % 1.87 %
Sequential Capital Expenditures Change (Q1 MRQ) -14.51 % -15.55 % -27.85 % -22.75 %
Y / Y Capital Expenditures Change (Q1 TTM) -25.57 % -1.45 % 2.01 % -10.89 %
Sequential Capital Expenditures Change (Q1 TTM) 15.92 % 0.06 % 1.16 % 0.11 %
Capital Expenditures 5 Year Avg. Change - 10.08 % 11.27 % 9.33 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.